We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Glasgow-Blatschford Score Validation in Digestive Hemorrhage

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01029626
Recruitment Status : Unknown
Verified October 2009 by University Hospital, Geneva.
Recruitment status was:  Recruiting
First Posted : December 10, 2009
Last Update Posted : December 10, 2009
Information provided by:
University Hospital, Geneva

Brief Summary:
The purpose of this study is to validate the Glasgow-Blatchford score for the stratification of patients with upper gastro-intestinal hemorrhage. This score is easy to calculate. It is mainly based on the hemoglobin, blood pressure and blood urea. if the score is zero, the bleeding is very low risk and the gastrointestinal endoscopy may be delayed and performed as an outpatient.

Condition or disease Intervention/treatment
Gastrointestinal Hemorrhage Procedure: Endoscopy

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 64 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: Glasgow-Blatschford Score Validation for Stratification of Patients With Digestive Hemorrhage
Study Start Date : October 2009
Estimated Primary Completion Date : June 2010
Estimated Study Completion Date : March 2011

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Arm Intervention/treatment
If the Glasgow-Blatchford score is zero, the endoscopy is delayed as an outpatient
Procedure: Endoscopy
Realization of an upper GI endoscopy

Primary Outcome Measures :
  1. Comparison of length of stay between patients with score equal to zero and above zero [ Time Frame: june 2010 ]

Secondary Outcome Measures :
  1. Determination of the proportion of low risk upper gastrointestinal bleeding [ Time Frame: june 2010 ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • To be admitted in the university hospital for a gastrointestinal hemorrhage (vomiting of red or black blood or melena)

Exclusion Criteria:

  • Age under 18
  • Pregnancy
  • Hemorrhage during hospitalisation
  • red rectal bleeding
  • No consent signed

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01029626

Contact: Marc Girardin, MD +41223729340 marc.girardin@hcuge.ch

Geneva University Hospital Recruiting
Geneva, Switzerland, 1211
Contact: Marc Girardin, MD    +41223729340    marc.girardin@hcuge.ch   
Principal Investigator: Marc Girardin, MD         
Sub-Investigator: Jean-Marc Dumonceau, MD         
Sponsors and Collaborators
University Hospital, Geneva
Principal Investigator: Marc Girardin, MD Geneva University Hospital